As the first trial of a DePuy Hip Recall Lawsuit is set to begin on Friday, Jan. 25, in Los Angeles, the Rottenstein Law Group is concerned about court records that reveal Johnson & Johnson’s knowledge that the DePuy ASR hip replacement would cause problems in recipients.
In a 2011 internal analysis of the DePuy ASR, revealed in court records (in In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court), Johnson & Johnson subsidiary DePuy Orthopaedics reported the metal-on-metal DePuy ASR hip implant would fail in 40 percent of patients after five years, according to a New York Times story. The analysis followed a 2010 recall, for which Johnson & Johnson reportedly took a special charge of $3 billion, according to theBaltimore Sun. Meanwhile, the company denied a British report on the device’s failure, the Times said.
“Johnson & Johnson needs to be held accountable,” said Rochelle Rottenstein, principal of the Rottenstein Law Group.
Read more : DePuy Hip Recall Update: Rottenstein Law Group Responds to Johnson & Johnson Revelation About DePuy ASR Failure Rate
In a 2011 internal analysis of the DePuy ASR, revealed in court records (in In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court), Johnson & Johnson subsidiary DePuy Orthopaedics reported the metal-on-metal DePuy ASR hip implant would fail in 40 percent of patients after five years, according to a New York Times story. The analysis followed a 2010 recall, for which Johnson & Johnson reportedly took a special charge of $3 billion, according to theBaltimore Sun. Meanwhile, the company denied a British report on the device’s failure, the Times said.
“Johnson & Johnson needs to be held accountable,” said Rochelle Rottenstein, principal of the Rottenstein Law Group.
Read more : DePuy Hip Recall Update: Rottenstein Law Group Responds to Johnson & Johnson Revelation About DePuy ASR Failure Rate
RSS Feed